NCT03878524 2024-03-04Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialOHSU Knight Cancer InstitutePhase 1 Terminated2 enrolled
NCT01650805 2014-11-17Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)Ariad PharmaceuticalsPhase 3 Terminated307 enrolled 11 charts
NCT01066468 2012-03-13Glivec/Gleevec Pediatric (Age 1 to Less Than 4) PK Study in CML, Ph+ ALL Patients and Other Glivec/Gleevec® Indicated Hematological Disorders.NovartisPhase 1 Terminated3 enrolled
NCT00245128 2012-01-13Imatinib Mesylate in Treating Patients With MyelofibrosisOHSU Knight Cancer InstitutePhase 2 Terminated10 enrolled 6 charts